Enhancing national prevention and treatment services for sex workers in Zimbabwe: a process evaluation of the SAPPH-IRe trial.


Journal

Health policy and planning
ISSN: 1460-2237
Titre abrégé: Health Policy Plan
Pays: England
ID NLM: 8610614

Informations de publication

Date de publication:
01 Jun 2019
Historique:
accepted: 26 04 2019
pubmed: 4 6 2019
medline: 24 4 2020
entrez: 4 6 2019
Statut: ppublish

Résumé

Targeted HIV interventions for female sex workers (FSW) combine biomedical technologies, behavioural change and community mobilization with the aim of empowering FSW and improving prevention and treatment. Understanding how to deliver combined interventions most effectively in sub-Saharan Africa is critical to the HIV response. The Sisters' Antiretroviral Programme for Prevention of HIV: an Integrated Response (SAPPH-Ire) randomized controlled trial in Zimbabwe tested an intervention to improve FSW engagement with HIV services. After 2 years, results of the trial showed no significant difference between study arms in proportion of FSW with HIV viral load ≥1000 copies/ml as steep declines occurred in both. We present the results of a process evaluation aiming to track the intervention's implementation, assess its feasibility and accessibility, and situate trial results within the national HIV policy context. We conducted a mixed methods study using data from routine programme statistics, qualitative interviews with participants and respondent driven surveys. The intervention proved feasible to deliver and was acceptable to FSW and providers. Intervention clinics saw more new FSW (4082 vs 2754), performed over twice as many HIV tests (2606 vs 1151) and nearly double the number of women were diagnosed with HIV (1042 vs 546). Community mobilization meetings in intervention sites also attracted higher numbers. We identified some gaps in programme fidelity: offering pre-exposure prophylaxis took time to engage FSW, viral load monitoring was not performed, and ratio of peer educators to FSW was lower than intended. During the trial, reaching FSW with HIV testing and treatment became a national priority, leading to increasing attendance at both intervention and control clinics. Throughout Zimbabwe, antiretroviral therapy coverage improved and HIV-stigma declined. Zimbabwe's changing HIV policy context appeared to contribute to positive improvements across the HIV care continuum for all FSW over the course of the trial. More intense community-based interventions for FSW may be needed to make further gains.

Identifiants

pubmed: 31157368
pii: 5510162
doi: 10.1093/heapol/czz037
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Pagination

337-345

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Joanna Busza (J)

Centre for Evaluation, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK.

Tarisai Chiyaka (T)

Centre for Sexual Health and HIV AIDS Research (CeSHHAR) Zimbabwe, 9 Monmouth Road, Harare, Zimbabwe.

Sithembile Musemburi (S)

Centre for Sexual Health and HIV AIDS Research (CeSHHAR) Zimbabwe, 9 Monmouth Road, Harare, Zimbabwe.

Elizabeth Fearon (E)

Centre for Evaluation, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK.

Calum Davey (C)

Centre for Evaluation, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK.

Sungai Chabata (S)

Centre for Sexual Health and HIV AIDS Research (CeSHHAR) Zimbabwe, 9 Monmouth Road, Harare, Zimbabwe.

Phillis Mushati (P)

Centre for Sexual Health and HIV AIDS Research (CeSHHAR) Zimbabwe, 9 Monmouth Road, Harare, Zimbabwe.

Jeffrey Dirawo (J)

Centre for Sexual Health and HIV AIDS Research (CeSHHAR) Zimbabwe, 9 Monmouth Road, Harare, Zimbabwe.

Sue Napierala (S)

RTI International, 351 California Street, Suite 500, San Francisco, CA, USA.

Andrew N Phillips (AN)

Institute for Global Health, UCL, Royal Free Hospital, Rowland Hill Street, London, UK and.

Frances M Cowan (FM)

Centre for Sexual Health and HIV AIDS Research (CeSHHAR) Zimbabwe, 9 Monmouth Road, Harare, Zimbabwe.
Department of International Public Health, Liverpool School of Tropical Medicine, Pembroke Pl, Liverpool, UK.

James R Hargreaves (JR)

Centre for Evaluation, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH